Decades of Using Roundup Led To Non-Hodgkins Lymphoma Diagnosis, Lawsuit Alleges

An Illinois woman indicates that after years of Roundup exposure, she was diagnosed with non-Hodgkins lymphoma due to side effects of glyphosate and other ingredients contained in the controversial weedkiller. 

The complaint (PDF) was filed this month by Patricia Lashock in the U.S. District Court for the Eastern District of Missouri, indicating that Monsanto Company failed to adequately warn consumers about the dangers of using Roundup.

Lashock regularly purchased and used Roundup and other Monsanto glyphosate-based herbicides from about 1977 through 2010, when she indicates that she was diagnosed with non-Hodgkins lymphoma.

Learn More About

Roundup Lawsuits

Exposure to RoundUp May Increase Risk of Non-Hodgkins Lymphoma and Other Cancers. Lawsuits Reviewed Nationwide.

Learn More About this Lawsuit See If You Qualify For Compensation

“Plaintiff maintains that Roundup and/or glyphosate is defective, dangerous to human health, unfit and unsuitable to be marketed and sold in commerce, and lacked proper warnings and directions as to the dangers associated with its use,” her lawsuit states. “Plaintiff’s injuries, like those striking thousands of similarly situated victims across the country, were avoidable.”

Concerns about the link between Roundup and non-Hodgkin’s lymphoma first arose in 2015, when the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate contained in Roundup as a probable human carcinogen.

The move sparked world-wide concerns about why Monsanto failed to provide warnings and recommend safety precautions for users of Roundup, and resulted in hundreds of similar Roundup lawsuits filed in courts nationwide.

As part of the on-going litigation, internal Monsanto documents produced during the discovery process have suggested that the manufacture knew about the cancer risks associated with the Roundup active ingredients for years.

Lashock’s claim will be consolidated with other cases pending in the federal court system, which are centralized as part of a multidistrict litigation (MDL) pending before U.S. District Judge Vince Chhabria in the Northern District of California. The litigation has been consolidated for pretrial proceedings to reduce duplicative discovery into common issues, prevent conflicting rulings from different Courts and to serve the convenience of the parties, witnesses and the judicial system.

As part of the coordinated MDL proceedings, Judge Chhabria has previously determined that the Roundup litigation will be bifurcated, first addressing general causation about the link between the widely used weedkiller and non-Hodgkins lymphoma, as well as other forms of cancer, before addressing case-specific issues about whether Roundup caused cancer for each individual plaintiff.

Following resolution of any motions to dismiss based on general causation, if a Roundup cancer settlements or another resolution for the litigation is not reached during the first phase of discovery, it is expected that Judge Chhabria will establish a bellwether process, where a small group of cases will be prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the lawsuits.

Image Credit: Photo Courtesy of Mike Mozart via Flickr Creative Commons

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted today)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.